SEC Form 4 · accession 0001209191-15-078471
ReShape Lifesciences Inc. · RSLS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dan W Gladney
Officer — Chief Executive Officer · Director
Period of report
Oct 28, 2015
Accepted (ET)
Nov 4, 2015 · 5:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001371217
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.25 | Oct 28, 2015 | A | 7,750,000 | A | Oct 28, 2016 | Oct 28, 2025 | Common Stock | 7,750,000 | 7,750,000 | D |
Explanation of responses
- F1Vests as to 25% one year from the date of the employment agreement on the date noted and thereafter in cumulative installments of 1/36th per month.